The study explores how similarities between the SARS-CoV-2 Spike protein and commensal microbiota can lead to cross-regulation of antibody responses, potentially impacting immune responses and vaccine development.
- Antibodies produced against the SARS-CoV-2 Spike protein may also cross-react with commensal microbiota. - This cross-reactivity is due to molecular mimicry, where similar structures in the Spike protein and commensal bacteria trigger the immune response. - The presence of cross-reactive antibodies may have implications for both the immune response to SARS-CoV-2 and the maintenance of a healthy microbiota. - Further research is needed to understand the extent and consequences of cross-regulation between antibody responses and commensal microbiota.
This is from ScienceDirect in 2023 at Link.
1. Cross-regulation 2. Antibody responses 3. SARS-CoV-2 Spike protein 4. Commensal microbiota 5. Molecular mimicry